Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins
- PMID: 21715507
- PMCID: PMC3165820
- DOI: 10.1128/JVI.00736-11
Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins
Abstract
Sexual transmission of human immunodeficiency virus type 1 (HIV-1) across mucosal barriers is responsible for the vast majority of new infections. This relatively inefficient process results in the transmission of a single transmitted/founder (T/F) virus, from a diverse viral swarm in the donor, in approximately 80% of cases. Here we compared the biological activities of 24 clade B T/F envelopes (Envs) with those from 17 chronic controls to determine whether the genetic bottleneck that occurs during transmission is linked to a particular Env phenotype. To maximize the likelihood of an intact mucosal barrier in the recipients and to enhance the sensitivity of detecting phenotypic differences, only T/F Envs from individuals infected with a single T/F variant were selected. Using pseudotyping to assess Env function in single-round infectivity assays, we compared coreceptor tropism, CCR5 utilization efficiencies, primary CD4(+) T cell subset tropism, dendritic cell trans-infections, fusion kinetics, and neutralization sensitivities. T/F and chronic Envs were phenotypically equivalent in most assays; however, T/F Envs were modestly more sensitive to CD4 binding site antibodies b12 and VRC01, as well as pooled human HIV Ig. This finding was independently validated with a panel of 14 additional chronic HIV-1 Env controls. Moreover, the enhanced neutralization sensitivity was associated with more efficient binding of b12 and VRC01 to T/F Env trimers. These data suggest that there are subtle but significant structural differences between T/F and chronic clade B Envs that may have implications for HIV-1 transmission and the design of effective vaccines.
Figures
Similar articles
-
Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7.PLoS Pathog. 2012;8(5):e1002686. doi: 10.1371/journal.ppat.1002686. Epub 2012 May 31. PLoS Pathog. 2012. PMID: 22693444 Free PMC article.
-
Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.J Virol. 2017 Apr 13;91(9):e02425-16. doi: 10.1128/JVI.02425-16. Print 2017 May 1. J Virol. 2017. PMID: 28148796 Free PMC article.
-
Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5.J Virol. 2013 Mar;87(5):2401-11. doi: 10.1128/JVI.02964-12. Epub 2012 Dec 26. J Virol. 2013. PMID: 23269796 Free PMC article.
-
Conformation-Dependent Interactions Between HIV-1 Envelope Glycoproteins and Broadly Neutralizing Antibodies.AIDS Res Hum Retroviruses. 2018 Sep;34(9):794-803. doi: 10.1089/AID.2018.0102. Epub 2018 Jul 17. AIDS Res Hum Retroviruses. 2018. PMID: 29905080 Review.
-
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies.Retrovirology. 2018 Jul 28;15(1):51. doi: 10.1186/s12977-018-0434-1. Retrovirology. 2018. PMID: 30055632 Free PMC article. Review.
Cited by
-
HIV-1 subtype C transmitted founders modulate dendritic cell inflammatory responses.Retrovirology. 2020 Jul 2;17(1):17. doi: 10.1186/s12977-020-00526-0. Retrovirology. 2020. PMID: 32615983 Free PMC article.
-
Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.PLoS Pathog. 2016 Jul 19;12(7):e1005742. doi: 10.1371/journal.ppat.1005742. eCollection 2016 Jul. PLoS Pathog. 2016. PMID: 27434311 Free PMC article.
-
Longitudinal analysis of subtype C envelope tropism for memory CD4+ T cell subsets over the first 3 years of untreated HIV-1 infection.Retrovirology. 2020 Aug 6;17(1):24. doi: 10.1186/s12977-020-00532-2. Retrovirology. 2020. PMID: 32762760 Free PMC article.
-
Phenotypic properties of transmitted founder HIV-1.Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6626-33. doi: 10.1073/pnas.1304288110. Epub 2013 Mar 29. Proc Natl Acad Sci U S A. 2013. PMID: 23542380 Free PMC article.
-
HIV-1 Envelope Glycosylation and the Signal Peptide.Vaccines (Basel). 2021 Feb 19;9(2):176. doi: 10.3390/vaccines9020176. Vaccines (Basel). 2021. PMID: 33669676 Free PMC article. Review.
References
-
- Balotta C., et al. 1997. Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS 11:F67–F71 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous